Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Influence of thromboxane synthetase inhibitors on virus replication in human lung fibroblasts in vitro.

Fitzpatrick FA, Stringfellow D.

Biochem Biophys Res Commun. 1983 Oct 14;116(1):264-71.

PMID:
6315004
2.
3.

[Effect of thromboxane synthetase inhibitors on the action of bronchoactive agents and on arachidonate metabolism in the guinea pig tracheobronchopulmonary system].

Kitamura S, Ishihara Y, Takaku F.

Nihon Kyobu Shikkan Gakkai Zasshi. 1984 Jan;22(1):3-8. Japanese. No abstract available.

PMID:
6539836
4.

Inhibition of arachidonate metabolism by selected compounds in vitro with particular emphasis on the thromboxane A2 synthase pathway.

Tobias LD, Hamilton JG.

Adv Prostaglandin Thromboxane Res. 1980;6:453-6. No abstract available.

PMID:
6770605
5.

Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products.

Bertelé V, Falanga A, Tomasiak M, Chiabrando C, Cerletti C, de Gaetano G.

Blood. 1984 Jun;63(6):1460-6.

6.

Pulmonary vascular responses to thromboxane A2 as unmasked by OKY-1581. A novel inhibitor of thromboxane synthesis.

Kadowitz PJ, Nandiwada PA, Spannhake EW, Rosenson RS, McNamara DB, Hyman AL.

Chest. 1983 May;83(5 Suppl):72S-74S. No abstract available.

PMID:
6404609
8.

UK-37, 248, a novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity.

Randall MJ, Parry MJ, Hawkeswood E, Cross PE, Dickinson RP.

Thromb Res. 1981 Jul 1-15;23(1-2):145-62. No abstract available.

PMID:
6795753
9.

Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.

Gorman RR.

Adv Prostaglandin Thromboxane Res. 1980;6:417-25. No abstract available.

PMID:
6247892
10.

Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden death.

Lefer AM, Okamatsu S, Smith EF 3rd, Smith JB.

Thromb Res. 1981 Aug 1;23(3):265-73. No abstract available.

PMID:
6795758
11.

Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.

Chiabrando C, Broggini M, Castelli MG, Cozzi E, Castagnoli MN, Donelli MG, Garattini S, Giavazzi R, Fanelli R.

Cancer Res. 1987 Feb 15;47(4):988-91.

12.

A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors.

Fitzpatrick FA, Gorman RR.

Biochim Biophys Acta. 1978 Mar 1;539(2):162-72.

PMID:
629996
13.

Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid.

Gorman RR, Bundy GL, Peterson DC, Sun FF, Miller OV, Fitzpatrick FA.

Proc Natl Acad Sci U S A. 1977 Sep;74(9):4007-11.

15.
16.

Thromboxane synthase inhibition and perinatal pulmonary response to arachidonic acid.

Tod ML, Cassin S.

J Appl Physiol (1985). 1985 Mar;58(3):710-6.

PMID:
3920192
17.

Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.

Hiraku S, Wakitani K, Katsube N, Kawasaki A, Tsuboshima M, Naito J, Ujiie A, Komatsu H, Iizuka K.

Adv Prostaglandin Thromboxane Leukot Res. 1983;11:241-4. No abstract available.

PMID:
6221530
18.

Thromboxane synthetase inhibition as antithrombotic strategy.

Vermylen J, Defreyn G, Carreras LO, Machin SJ, Van Schaeren J, Verstraete M.

Lancet. 1981 May 16;1(8229):1073-5.

PMID:
6112447
19.

The effects of aspirin and OKY-1581 on the metabolism of exogenous arachidonic acid in rat alveolar macrophages.

Punnonen K, Uotila P, Mäntylä E.

Res Commun Chem Pathol Pharmacol. 1984 Jun;44(3):367-74.

PMID:
6431566
20.

Supplemental Content

Support Center